Common Contracts
4 similar Credit Agreement contracts by Coty Inc., E TRADE FINANCIAL Corp, PDL Biopharma, Inc.
AMENDMENT NO. 1Credit Agreement • November 4th, 2015 • E TRADE FINANCIAL Corp • Savings institution, federally chartered • New York
AMENDMENT NO. 1 (this “Amendment”) dated as of September 16, 2015 relating to the CREDIT AGREEMENT, dated as of November 10, 2014 (as amended, amended and restated, supplemented or otherwise modified prior to the date hereof, the “Credit Agreement”), among E*TRADE FINANCIAL CORPORATION, a Delaware corporation (the “Borrower”), JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, including any successor thereto, the “Administrative Agent”), MORGAN STANLEY SENIOR FUNDING, INC., as syndication agent and each lender from time to time party thereto (collectively, the “Lenders” and individually, a “Lender”).
800,000,000 CREDIT AGREEMENTCredit Agreement • March 27th, 2015 • Coty Inc. • Perfumes, cosmetics & other toilet preparations • New York
600,000,000 CREDIT AGREEMENTCredit Agreement • October 2nd, 2014 • Coty Inc. • Perfumes, cosmetics & other toilet preparations • New York
CREDIT AGREEMENT, dated as of September 29, 2014 (this “Agreement”), among COTY INC., a Delaware corporation (the “Borrower”), the banks, financial institutions or other entities from time to time parties to this Agreement (as more specifically defined below, the “Lenders”), BANK OF AMERICA, N.A., MORGAN STANLEY MUFG LOAN PARTNERS, LLC and WELLS FARGO BANK, N.A., as syndication agents (in such capacities, the “Syndication Agents”) and JPMORGAN CHASE BANK, N.A., as administrative agent.
CREDIT AGREEMENT dated as of October 28, 2013, among PDL BIOPHARMA, INC., as Borrower, THE LENDERS PARTY HERETO and ROYAL BANK OF CANADA, as Administrative Agent RBC CAPITAL MARKETS* and WELLS FARGO SECURITIES, LLC as Joint Lead Arrangers and Joint...Credit Agreement • October 30th, 2013 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
CREDIT AGREEMENT dated as of October 28, 2013 (this “Agreement”), among PDL BIOPHARMA, INC., a Delaware corporation (the “Borrower”), the LENDERS party hereto and ROYAL BANK OF CANADA, as Administrative Agent.
